Study: Wearers of 1-Day Acuvue Moist report low incidence of ocular adverse events

A year-long study of 1-Day Acuvue TruEye and 1-Day Acuvue Moist brands designed to observe “real-life” contact lens wear found that subjects who wore 1-Day Acuvue Moist reported low incidence of adverse events.

Orlando, FL-A year-long study of 1-Day Acuvue TruEye and 1-Day Acuvue Moist brands designed to observe “real-life” contact lens wear found that subjects who wore 1-Day Acuvue Moist reported low incidence of adverse events.

The study observed 1,171 subjects, ages 8 to 76 years old, at 37 clinical sites across the U.S. According to the study, only 3 non-serious, contact lens-related adverse events resulted in visits to an ECP office “in 471 years of patient wear (0.6%/year including no reported symptomatic corneal infiltrative events).”

For wearers of the 1-Day Acuvue TruEye brand,  the study found the rate of adverse events that resulted in an office visit was 1.6 per year, of which 0.4% per year were symptomatic corneal infiltrative events.

“The rate of adverse events observed in this study is between 4 and 10 times lower than that reported in any other studies that evaluated reusable lenses published to date,” according to lead author Robin L Chalmers, OD, FAAO, FBCLA, clinical trial consultant. “Of 1,171 wearers of these 2 daily disposable contact lens brands, only 11, or approximately 1%, had contact lens-related complications that prompted a visit to the eye care practitioner, and only 2 events were symptomatic CIEs.”

Related Videos
 Valerie M. Kattouf, OD, associate professor of optometry and chief of the Dr. Robert and Lena Lewenson Center for Pediatric and Binocular Vision, Illinois College of Optometry, speaks with Optometry Times®' Alex Delaney-Gesing on key highlights and takeaways from her 2022 Vision Expo West presentation titled "Myopia Control."
Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, shares highlights from her discussion titled, "Myopia management: past, present, and future," presented during this year's 115th annual SCOPA meeting.
© 2023 MJH Life Sciences

All rights reserved.